92 related articles for article (PubMed ID: 16548239)
1. [Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori].
Egashira T
Rinsho Byori; 2006 Feb; 54(2):176-83. PubMed ID: 16548239
[TBL] [Abstract][Full Text] [Related]
2. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Furuta T; Sagehashi Y; Shirai N; Sugimoto M; Nakamura A; Kodaira M; Kenmotsu K; Nagano M; Egashira T; Ueda K; Yoneyama M; Ohashi K; Ishizaki T; Hishida A
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):564-73. PubMed ID: 15952098
[TBL] [Abstract][Full Text] [Related]
3. Personalized treatment in the eradication therapy for Helicobacter pylori.
Jinda S; Nakatani K; Nishioka J; Yasuda K; Soya Y; Hayashi A; Wada H; Nobori T
Int J Mol Med; 2011 Feb; 27(2):255-61. PubMed ID: 21132257
[TBL] [Abstract][Full Text] [Related]
4. Gastric Juice-Based Real-Time PCR for Tailored
Peng X; Song Z; He L; Lin S; Gong Y; Sun L; Zhao F; Gu Y; You Y; Zhou L; Zhang J
Int J Med Sci; 2017; 14(6):595-601. PubMed ID: 28638276
[TBL] [Abstract][Full Text] [Related]
5. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Kawai T; Yamagishi T; Yagi K; Kataoka M; Kawakami K; Sofuni A; Itoi T; Sakai Y; Moriyasu F; Osaka Y; Takagi Y; Aoki T; Rimbara E; Noguchi N; Sasatsu M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S171-4. PubMed ID: 19120893
[TBL] [Abstract][Full Text] [Related]
6. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
Furuta T; Sugimoto M; Shirai N; Matsushita F; Nakajima H; Kumagai J; Senoo K; Kodaira C; Nishino M; Yamade M; Ikuma M; Watanabe H; Umemura K; Ishizaki T; Hishida A
Aliment Pharmacol Ther; 2007 Sep; 26(5):693-703. PubMed ID: 17697203
[
